Aditxt, Inc. sold substantially all shares of its majority-owned subsidiary, Pearsanta, Inc., to MDNA Holdings Inc. for an undisclosed cash amount on August 12, 2026. The transaction includes a royalty agreement where Pearsanta pays Aditxt 2.5% of net revenue up to $2.5 million over ten years from first commercial sale. Additionally, Pearsanta must pay two milestone fees of $250,000 each: one triggered by raising $10 million in financing and another upon an IPO or change of control. Aditxt operates in the biotechnology sector.
